资源描述：
《中药咽炎方治疗急性咽炎的临床效果》由会员上传分享，免费在线阅读，更多相关内容在工程资料-天天文库。
1、中药咽炎方治疗急性咽炎的临床效果［摘要］目的探讨中药咽炎方治疗急性咽炎的临床效果。方法选取2012年3月〜2015年7月本院收治的142例急性咽炎患者作为研究对象，按就诊时体温及血常规检查结果分为感染组和混合组。将感染组随机分为感染治疗组和感染对照组，感染治疗组给予头抱克洛及中药咽炎方，感染对照组仅给予头抱克洛。同时将混合组随机分为混合治疗组和混合对照组，混合治疗组给予中药咽炎方，混合对照组给予利巴韦林。观察各组的疗效。结果感染治疗组的总有效率为85.71%,显著高于感染对照组的64.86%,差异有统
2、计学意义（P0.05）。结论中药咽炎方治疗急性咽炎疗效可靠，值得临床推广应用。［关键词］中药咽炎方；验方；急性咽炎［中图分类号］R766.14［文献标识码］A［文章编号］1674-4721(2016)05(c)-0097-03ClinicaleffectoftraditionalChinesemedicinepharyngitisprescrip廿oninthetreatmentofacutepharyngitisLIRui-linlWANGFang2ZHAOFang3YANGWei-zhuoll.D
3、epartmentofInternalMedicine，HospitalofXi'anJiaotongUniversity,Xizan710061,China；2.DepartmentofEndocrinology,Xi'anElectricityCentralHospital,Xizan710032,China；3.DepartmentofInternalMedicine,63870MilitaryHospitalofPLA,Huayin714200,China[Abstract]Objective
4、ToexploretheclinicaleffectoftraditionalChinesemedicine(TCM)pharyngitisprescript!oninthetreatmentofacutepharyngitis・Methods142patientswithacutepharyngitisinourhospitalfromMarch2012toJuly2015wereselectedanddividedintotheinfectiongroupandthemixedgroupaccor
5、dingtobodytemperatureandresultsofbloodroutineexamination.Patientsintheinfectiongroupwererandomlydividedintotheinfectiontreatmentgroupandtheinfectioncontrolgroup,theinfectiontreatmentgroupwasgivencefaclorandTCMpharyngitisprescript!on，theinfectioncontrolg
6、roupwastreatedwithsinglecefaclor.Meanwhile,patientsinthemixedgroupweredividedintothemixedtreatmentgroupandthemixedcontrolgroup,themixedtreatmentgroupwasgivenTCMpharyngitisprescription,themixedcontrolgroupwastreatedwithribavirin.Theeffectofeachgroupwasco
7、mpared・ResultsThetotaleffectiverateintheinfectiontreatmentgroupwas85.71%,whichwashigherthan64.86%intheinfectioncontrolgroup,withsignificantdifference(P0.05)・ConclusionTCMpharyngitisprescriptionhasreliableclinicaleffectinthetreatmentofacutepharyngitis,it
8、isworthyofclinicalpromotionandapplication.[Keywords]TraditionalChinesemedicinepharyngitisprescription；Provedprescription；Acutepharyngitis急性咽炎是咽喉部黏膜、黏膜下及其周围淋巴组织的急性感染性炎症，为上呼吸道感染的一部分[1],是耳鼻喉科和内科门诊的常见病、多发病，发病率占耳鼻喉科疾病的2%〜6%[2]。据报道，全球每
